Immediate impact on Indian pharma exports unlikely: Pharmexcil chairman Namit Joshi
“Bulk of the exports from country are generics and most large pharma companies already operate U.S. manufacturing or repackaging firms,” Namit Joshi said
“Bulk of the exports from country are generics and most large pharma companies already operate U.S. manufacturing or repackaging firms,” Namit Joshi said
What's Your Reaction?
